Skip to main content
Erschienen in: Current Gastroenterology Reports 5/2019

01.05.2019 | Large Intestine (B Cash and R Chokshi, Section Editors)

A Practical Guide to Biofeedback Therapy for Pelvic Floor Disorders

verfasst von: Susrutha Puthanmadhom Narayanan, Adil E. Bharucha

Erschienen in: Current Gastroenterology Reports | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Biofeedback therapy (BFT) is effective for managing pelvic floor disorders (i.e., defecatory disorders and fecal incontinence). However, even in controlled clinical trials, only approximately 60% of patients with defecatory disorders experienced long-term improvement. The review serves to update practitioners on recent advances and to identify practical obstacles to providing biofeedback therapy.

Recent Findings

The efficacy and safety of biofeedback therapy have been evaluated in defecatory disorders, fecal incontinence, and levator ani syndrome. Recent studies looked at outcomes in specific patient sub-populations and predictors of a response to biofeedback therapy.

Summary

Biofeedback therapy is effective for managing defecatory disorders, fecal incontinence, and levator ani syndrome. Patients who have a lower bowel satisfaction score and use digital maneuvers fare better. Biofeedback therapy is recommended for patients with fecal incontinence who do not respond to conservative management. A subset of patients with levator ani syndrome who have dyssynergic defecation are more likely to respond to biofeedback therapy.
Literatur
1.
Zurück zum Zitat Rao SS, Bharucha AE, Chiarioni G, Felt-Bersma R, Knowles C, Malcolm A, et al. Functional anorectal disorders. Gastroenterology. 2016;150:1430–1442.e4.CrossRef Rao SS, Bharucha AE, Chiarioni G, Felt-Bersma R, Knowles C, Malcolm A, et al. Functional anorectal disorders. Gastroenterology. 2016;150:1430–1442.e4.CrossRef
2.
Zurück zum Zitat Bharucha AE, Wald A. Chronic constipation. Mayo Clin Proc. 2019; In press. Bharucha AE, Wald A. Chronic constipation. Mayo Clin Proc. 2019; In press.
3.
Zurück zum Zitat Wald A, Bharucha AE, Cosman BC, Whitehead WE. ACG clinical guideline: management of benign anorectal disorders. Am J Gastroenterol. 2014;109(8):1141–57 (Quiz) 058.CrossRef Wald A, Bharucha AE, Cosman BC, Whitehead WE. ACG clinical guideline: management of benign anorectal disorders. Am J Gastroenterol. 2014;109(8):1141–57 (Quiz) 058.CrossRef
5.
Zurück zum Zitat Bharucha AE, Dunivan G, Goode PS, Lukacz ES, Markland AD, Matthews CA, et al. Epidemiology, pathophysiology, and classification of fecal incontinence: state of the science summary for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) workshop. Am J Gastroenterol. 2015;110(1):127–36.CrossRef Bharucha AE, Dunivan G, Goode PS, Lukacz ES, Markland AD, Matthews CA, et al. Epidemiology, pathophysiology, and classification of fecal incontinence: state of the science summary for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) workshop. Am J Gastroenterol. 2015;110(1):127–36.CrossRef
6.
Zurück zum Zitat Bharucha AE, Rao SSC, Shin AS. Surgical interventions and the use of device-aided therapy for the treatment of fecal incontinence and defecatory disorders. Clin Gastroenterol Hepatol. 2017;15(12):1844–54.CrossRef Bharucha AE, Rao SSC, Shin AS. Surgical interventions and the use of device-aided therapy for the treatment of fecal incontinence and defecatory disorders. Clin Gastroenterol Hepatol. 2017;15(12):1844–54.CrossRef
7.
Zurück zum Zitat Whitehead WE, Rao SSC, Lowry A, Nagle D, Varma M, Bitar KN, et al. Treatment of fecal incontinence: state of the science summary for the National Institute of Diabetes and Digestive and Kidney Diseases workshop. Am J Gastroenterol. 2015;110(1):127–36.CrossRef Whitehead WE, Rao SSC, Lowry A, Nagle D, Varma M, Bitar KN, et al. Treatment of fecal incontinence: state of the science summary for the National Institute of Diabetes and Digestive and Kidney Diseases workshop. Am J Gastroenterol. 2015;110(1):127–36.CrossRef
8.
Zurück zum Zitat •• Chiarioni G, Nardo A, Vantini I, Romito A, Whitehead WE. Biofeedback is superior to electrogalvanic stimulation and massage for treatment of levator ani syndrome. Gastroenterology. 2010;138(4):1321–9. BFT is superior to electrogalvanic stimulation and pelvic floor massage in LAS associated with tenderness on levator traction. Patients treated with EMG-BFT reported greater symptom improvement i.e., higher rate of patient reported adequate relief, fewer pain days per month, and lower pain intensity. CrossRef •• Chiarioni G, Nardo A, Vantini I, Romito A, Whitehead WE. Biofeedback is superior to electrogalvanic stimulation and massage for treatment of levator ani syndrome. Gastroenterology. 2010;138(4):1321–9. BFT is superior to electrogalvanic stimulation and pelvic floor massage in LAS associated with tenderness on levator traction. Patients treated with EMG-BFT reported greater symptom improvement i.e., higher rate of patient reported adequate relief, fewer pain days per month, and lower pain intensity. CrossRef
9.
Zurück zum Zitat •• Rao SS, Seaton K, Miller M, Brown K, Nygaard I, Stumbo P, et al. Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol Hepatol. 2007;5(3):331–8. BFT is more effective than sham and standard treatment in patients with DD. In this study, patients who were treated with manometry-guided BFT had significant improvement in defecation index, balloon expulsion time, Complete Spontaneous Bowel Movement Score, colon transit, and global bowel satisfaction. CrossRef •• Rao SS, Seaton K, Miller M, Brown K, Nygaard I, Stumbo P, et al. Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol Hepatol. 2007;5(3):331–8. BFT is more effective than sham and standard treatment in patients with DD. In this study, patients who were treated with manometry-guided BFT had significant improvement in defecation index, balloon expulsion time, Complete Spontaneous Bowel Movement Score, colon transit, and global bowel satisfaction. CrossRef
10.
Zurück zum Zitat •• Rao SS, Benninga MA, Bharucha AE, Chiarioni G, Di Lorenzo C, Whitehead WE. ANMS-ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders. Neurogastroenterol Motil. 2015;27(5):594–609. BFT recommended for short and long-term treatment of DD (Level I, Grade A), and FI (Level II, Grade B). BFT may be useful for short-term treatment of LAS with DD (Level II, Grade B). It is not recommended for the routine treatment of children with Functional Constipation, with or without overflow FI (Level 1, Grade D).CrossRef •• Rao SS, Benninga MA, Bharucha AE, Chiarioni G, Di Lorenzo C, Whitehead WE. ANMS-ESNM position paper and consensus guidelines on biofeedback therapy for anorectal disorders. Neurogastroenterol Motil. 2015;27(5):594–609. BFT recommended for short and long-term treatment of DD (Level I, Grade A), and FI (Level II, Grade B). BFT may be useful for short-term treatment of LAS with DD (Level II, Grade B). It is not recommended for the routine treatment of children with Functional Constipation, with or without overflow FI (Level 1, Grade D).CrossRef
11.
Zurück zum Zitat Bleijenberg G, Kuijpers HC. Biofeedback treatment of constipation: a comparison of two methods. Am J Gastroenterol. 1994;89(7):1021–6.PubMed Bleijenberg G, Kuijpers HC. Biofeedback treatment of constipation: a comparison of two methods. Am J Gastroenterol. 1994;89(7):1021–6.PubMed
12.
Zurück zum Zitat Chiotakakou-Faliakou E, Kamm MA, Roy AJ, Storrie JB, Turner IC. Biofeedback provides long-term benefit for patients with intractable, slow and normal transit constipation. Gut. 1998;42(4):517–21.CrossRef Chiotakakou-Faliakou E, Kamm MA, Roy AJ, Storrie JB, Turner IC. Biofeedback provides long-term benefit for patients with intractable, slow and normal transit constipation. Gut. 1998;42(4):517–21.CrossRef
13.
Zurück zum Zitat Chiarioni G, Salandini L, Whitehead WE. Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology. 2005;129(1):86–97.CrossRef Chiarioni G, Salandini L, Whitehead WE. Biofeedback benefits only patients with outlet dysfunction, not patients with isolated slow transit constipation. Gastroenterology. 2005;129(1):86–97.CrossRef
14.
Zurück zum Zitat •• Chiarioni G, Whitehead WE, Pezza V, Morelli A, Bassotti G. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology. 2006;130(3):657–64. BFT is more effective than PEG laxative in improving symptoms and anorectal manometry in patients with DD, and the benefits are maintained up to 2 years.CrossRef •• Chiarioni G, Whitehead WE, Pezza V, Morelli A, Bassotti G. Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology. 2006;130(3):657–64. BFT is more effective than PEG laxative in improving symptoms and anorectal manometry in patients with DD, and the benefits are maintained up to 2 years.CrossRef
15.
Zurück zum Zitat •• Heymen S, Scarlett Y, Jones K, Ringel Y, Drossman D, Whitehead WE. Randomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipation. Dis Colon Rectum. 2007;50(4):428–41.CrossRef •• Heymen S, Scarlett Y, Jones K, Ringel Y, Drossman D, Whitehead WE. Randomized, controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssynergia-type constipation. Dis Colon Rectum. 2007;50(4):428–41.CrossRef
16.
Zurück zum Zitat Rao SS, Valestin J, Brown CK, Zimmerman B, Schulze K. Long-term efficacy of biofeedback therapy for dyssynergic defecation: randomized controlled trial. Am J Gastroenterol. 2010;105(4):890–6.CrossRef Rao SS, Valestin J, Brown CK, Zimmerman B, Schulze K. Long-term efficacy of biofeedback therapy for dyssynergic defecation: randomized controlled trial. Am J Gastroenterol. 2010;105(4):890–6.CrossRef
17.
Zurück zum Zitat Simon MA, Bueno AM. Efficacy of biofeedback therapy in the treatment of dyssynergic defecation in community-dwelling elderly women. J Clin Gastroenterol. 2017;51(10):e90–e4.CrossRef Simon MA, Bueno AM. Efficacy of biofeedback therapy in the treatment of dyssynergic defecation in community-dwelling elderly women. J Clin Gastroenterol. 2017;51(10):e90–e4.CrossRef
18.
Zurück zum Zitat Rezaie A, Gu P, Kaplan GG, Pimentel M, Al-Darmaki AK. Dyssynergic defecation in inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis. 2018;24(5):1065–73.CrossRef Rezaie A, Gu P, Kaplan GG, Pimentel M, Al-Darmaki AK. Dyssynergic defecation in inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis. 2018;24(5):1065–73.CrossRef
19.
Zurück zum Zitat Koutsomanis D, Lennard-Jones JE, Roy AJ, Kamm MA. Controlled randomised trial of visual biofeedback versus muscle training without a visual display for intractable constipation. Gut. 1995;37(1):95–9.CrossRef Koutsomanis D, Lennard-Jones JE, Roy AJ, Kamm MA. Controlled randomised trial of visual biofeedback versus muscle training without a visual display for intractable constipation. Gut. 1995;37(1):95–9.CrossRef
20.
Zurück zum Zitat •• Woodward S, Norton C, Chiarelli P. Biofeedback for treatment of chronic idiopathic constipation in adults. Cochrane Database Syst Rev. 2014;(3):Cd008486. https://doi.org/10.1002/14651858.CD008486.pub2. Due to heterogeneity in included studies, no firm conclusion could be drawn regarding the utility of BFT in chronic constipation. •• Woodward S, Norton C, Chiarelli P. Biofeedback for treatment of chronic idiopathic constipation in adults. Cochrane Database Syst Rev. 2014;(3):Cd008486. https://​doi.​org/​10.​1002/​14651858.​CD008486.​pub2. Due to heterogeneity in included studies, no firm conclusion could be drawn regarding the utility of BFT in chronic constipation.
21.
Zurück zum Zitat Loening-Baucke V. Biofeedback treatment for chronic constipation and encopresis in childhood: long-term outcome. Pediatrics. 1995;96(1 Pt 1):105–10.PubMed Loening-Baucke V. Biofeedback treatment for chronic constipation and encopresis in childhood: long-term outcome. Pediatrics. 1995;96(1 Pt 1):105–10.PubMed
22.
Zurück zum Zitat van der Plas RN, Benninga MA, Buller HA, Bossuyt PM, Akkermans LM, Redekop WK, et al. Biofeedback training in treatment of childhood constipation: a randomised controlled study. Lancet (London, England). 1996;348(9030):776–80.CrossRef van der Plas RN, Benninga MA, Buller HA, Bossuyt PM, Akkermans LM, Redekop WK, et al. Biofeedback training in treatment of childhood constipation: a randomised controlled study. Lancet (London, England). 1996;348(9030):776–80.CrossRef
23.
Zurück zum Zitat van Ginkel R, Buller HA, Boeckxstaens GE, van Der Plas RN, Taminiau JA, Benninga MA. The effect of anorectal manometry on the outcome of treatment in severe childhood constipation: a randomized, controlled trial. Pediatrics. 2001;108(1):E9.CrossRef van Ginkel R, Buller HA, Boeckxstaens GE, van Der Plas RN, Taminiau JA, Benninga MA. The effect of anorectal manometry on the outcome of treatment in severe childhood constipation: a randomized, controlled trial. Pediatrics. 2001;108(1):E9.CrossRef
24.
Zurück zum Zitat Borowitz SM, Cox DJ, Sutphen JL, Kovatchev B. Treatment of childhood encopresis: a randomized trial comparing three treatment protocols. J Pediatr Gastroenterol Nutr. 2002;34(4):378–84.CrossRef Borowitz SM, Cox DJ, Sutphen JL, Kovatchev B. Treatment of childhood encopresis: a randomized trial comparing three treatment protocols. J Pediatr Gastroenterol Nutr. 2002;34(4):378–84.CrossRef
25.
Zurück zum Zitat Sunic-Omejc M, Mihanovic M, Bilic A, Jurcic D, Restek-Petrovic B, Maric N, et al. Efficiency of biofeedback therapy for chronic constipation in children. Coll Antropolo. 2002;26(Suppl):93–101. Sunic-Omejc M, Mihanovic M, Bilic A, Jurcic D, Restek-Petrovic B, Maric N, et al. Efficiency of biofeedback therapy for chronic constipation in children. Coll Antropolo. 2002;26(Suppl):93–101.
26.
Zurück zum Zitat Jarzebicka D, Sieczkowska J, Dadalski M, Kierkus J, Ryzko J, Oracz G. Evaluation of the effectiveness of biofeedback therapy for functional constipation in children. Turk J Gastroenterol. 2016;27(5):433–8.CrossRef Jarzebicka D, Sieczkowska J, Dadalski M, Kierkus J, Ryzko J, Oracz G. Evaluation of the effectiveness of biofeedback therapy for functional constipation in children. Turk J Gastroenterol. 2016;27(5):433–8.CrossRef
27.
Zurück zum Zitat Patcharatrakul T, Valestin J, Schmeltz A, Schulze K, Rao SSC. Factors associated with response to biofeedback therapy for dyssynergic defecation. Clin Gastroenterol Hepatol. 2018;16(5):715–21.CrossRef Patcharatrakul T, Valestin J, Schmeltz A, Schulze K, Rao SSC. Factors associated with response to biofeedback therapy for dyssynergic defecation. Clin Gastroenterol Hepatol. 2018;16(5):715–21.CrossRef
28.
Zurück zum Zitat Glia A, Gylin M, Gullberg K, Lindberg G. Biofeedback retraining in patients with functional constipation and paradoxical puborectalis contraction: comparison of anal manometry and sphincter electromyography for feedback. Dis Colon Rectum. 1997;40(8):889–95.CrossRef Glia A, Gylin M, Gullberg K, Lindberg G. Biofeedback retraining in patients with functional constipation and paradoxical puborectalis contraction: comparison of anal manometry and sphincter electromyography for feedback. Dis Colon Rectum. 1997;40(8):889–95.CrossRef
29.
Zurück zum Zitat Pourmomeny AA, Emami MH, Amooshahi M, Adibi P. Comparing the efficacy of biofeedback and balloon-assisted training in the treatment of dyssynergic defecation. Can J Gastroenterol. 2011;25(2):89–92.CrossRef Pourmomeny AA, Emami MH, Amooshahi M, Adibi P. Comparing the efficacy of biofeedback and balloon-assisted training in the treatment of dyssynergic defecation. Can J Gastroenterol. 2011;25(2):89–92.CrossRef
30.
Zurück zum Zitat Ozturk R, Niazi S, Stessman M, Rao SS. Long-term outcome and objective changes of anorectal function after biofeedback therapy for faecal incontinence. Aliment Pharmacol Ther. 2004;20(6):667–74.CrossRef Ozturk R, Niazi S, Stessman M, Rao SS. Long-term outcome and objective changes of anorectal function after biofeedback therapy for faecal incontinence. Aliment Pharmacol Ther. 2004;20(6):667–74.CrossRef
31.
Zurück zum Zitat Vasant DH, Solanki K, Balakrishnan S, Radhakrishnan NV. Integrated low-intensity biofeedback therapy in fecal incontinence: evidence that “good” in-home anal sphincter exercise practice makes perfect. Neurogastroenterol Motil. 2017;29(1). https://doi.org/10.1111/nmo.1291. Vasant DH, Solanki K, Balakrishnan S, Radhakrishnan NV. Integrated low-intensity biofeedback therapy in fecal incontinence: evidence that “good” in-home anal sphincter exercise practice makes perfect. Neurogastroenterol Motil. 2017;29(1). https://​doi.​org/​10.​1111/​nmo.​1291.
32.
Zurück zum Zitat Buser WD, Miner PB Jr. Delayed rectal sensation with fecal incontinence. Successful treatment using anorectal manometry. Gastroenterology. 1986;91(5):1186–91.CrossRef Buser WD, Miner PB Jr. Delayed rectal sensation with fecal incontinence. Successful treatment using anorectal manometry. Gastroenterology. 1986;91(5):1186–91.CrossRef
33.
Zurück zum Zitat Chiarioni G, Bassotti G, Stanganini S, Vantini I, Whitehead WE. Sensory retraining is key to biofeedback therapy for formed stool fecal incontinence. Am J Gastroenterol. 2002;97(1):109–17.CrossRef Chiarioni G, Bassotti G, Stanganini S, Vantini I, Whitehead WE. Sensory retraining is key to biofeedback therapy for formed stool fecal incontinence. Am J Gastroenterol. 2002;97(1):109–17.CrossRef
34.
Zurück zum Zitat Wald A, Tunuguntla AK. Anorectal sensorimotor dysfunction in fecal incontinence and diabetes mellitus. Modification with biofeedback therapy. N Engl J Med. 1984;310(20):1282–7.CrossRef Wald A, Tunuguntla AK. Anorectal sensorimotor dysfunction in fecal incontinence and diabetes mellitus. Modification with biofeedback therapy. N Engl J Med. 1984;310(20):1282–7.CrossRef
35.
Zurück zum Zitat Norton C, Chelvanayagam S, Wilson-Barnett J, Redfern S, Kamm MA. Randomized controlled trial of biofeedback for fecal incontinence. Gastroenterology. 2003;125(5):1320–9.CrossRef Norton C, Chelvanayagam S, Wilson-Barnett J, Redfern S, Kamm MA. Randomized controlled trial of biofeedback for fecal incontinence. Gastroenterology. 2003;125(5):1320–9.CrossRef
36.
Zurück zum Zitat •• Heymen S, Scarlett Y, Jones K, Ringel Y, Drossman D, Whitehead WE. Randomized controlled trial shows biofeedback to be superior to pelvic floor exercises for fecal incontinence. Dis Colon Rectum. 2009;52(10):1730–7. BFT added to pelvic floor exercise was more effective than pelvic floor exercises alone in FI patients who did not respond to conservative management. CrossRef •• Heymen S, Scarlett Y, Jones K, Ringel Y, Drossman D, Whitehead WE. Randomized controlled trial shows biofeedback to be superior to pelvic floor exercises for fecal incontinence. Dis Colon Rectum. 2009;52(10):1730–7. BFT added to pelvic floor exercise was more effective than pelvic floor exercises alone in FI patients who did not respond to conservative management. CrossRef
38.
Zurück zum Zitat Jelovsek JE, Markland AD, Whitehead WE, Barber MD, Newman DK, Rogers RG, et al. Controlling anal incontinence in women by performing anal exercises with manometric-assisted biofeedback or loperamide: the capable trial. Female Pelvic Med Reconstr Surg. 2017;23(5S):S1–S16. Jelovsek JE, Markland AD, Whitehead WE, Barber MD, Newman DK, Rogers RG, et al. Controlling anal incontinence in women by performing anal exercises with manometric-assisted biofeedback or loperamide: the capable trial. Female Pelvic Med Reconstr Surg. 2017;23(5S):S1–S16.
39.
Zurück zum Zitat Sjodahl J, Walter SA, Johansson E, Ingemansson A, Ryn AK, Hallbook O. Combination therapy with biofeedback, loperamide, and stool-bulking agents is effective for the treatment of fecal incontinence in women—a randomized controlled trial. Scand J Gastroenterol. 2015;50(8):965–74.CrossRef Sjodahl J, Walter SA, Johansson E, Ingemansson A, Ryn AK, Hallbook O. Combination therapy with biofeedback, loperamide, and stool-bulking agents is effective for the treatment of fecal incontinence in women—a randomized controlled trial. Scand J Gastroenterol. 2015;50(8):965–74.CrossRef
40.
Zurück zum Zitat Mazor Y, Ejova A, Andrews A, Jones M, Kellow J, Malcolm A. Long-term outcome of anorectal biofeedback for treatment of fecal incontinence. Neurogastroenterol Motil. 2018;30:e13389.CrossRef Mazor Y, Ejova A, Andrews A, Jones M, Kellow J, Malcolm A. Long-term outcome of anorectal biofeedback for treatment of fecal incontinence. Neurogastroenterol Motil. 2018;30:e13389.CrossRef
41.
Zurück zum Zitat Dehli T, Stordahl A, Vatten LJ, Romundstad PR, Mevik K, Sahlin Y, et al. Sphincter training or anal injections of dextranomer for treatment of anal incontinence: a randomized trial. Scand J Gastroenterol. 2013;48(3):302–10.CrossRef Dehli T, Stordahl A, Vatten LJ, Romundstad PR, Mevik K, Sahlin Y, et al. Sphincter training or anal injections of dextranomer for treatment of anal incontinence: a randomized trial. Scand J Gastroenterol. 2013;48(3):302–10.CrossRef
42.
Zurück zum Zitat Naimy N, Lindam AT, Bakka A, Faerden AE, Wiik P, Carlsen E, et al. Biofeedback vs. electrostimulation in the treatment of postdelivery anal incontinence: a randomized, clinical trial. Dis Colon Rectum. 2007;50(12):2040–6.CrossRef Naimy N, Lindam AT, Bakka A, Faerden AE, Wiik P, Carlsen E, et al. Biofeedback vs. electrostimulation in the treatment of postdelivery anal incontinence: a randomized, clinical trial. Dis Colon Rectum. 2007;50(12):2040–6.CrossRef
43.
Zurück zum Zitat Collins J, Mazor Y, Jones M, Kellow J, Malcolm A. Efficacy of anorectal biofeedback in scleroderma patients with fecal incontinence: a case-control study. Scand J Gastroenterol. 2016;51(12):1433–8.CrossRef Collins J, Mazor Y, Jones M, Kellow J, Malcolm A. Efficacy of anorectal biofeedback in scleroderma patients with fecal incontinence: a case-control study. Scand J Gastroenterol. 2016;51(12):1433–8.CrossRef
44.
Zurück zum Zitat Laforest A, Bretagnol F, Mouazan AS, Maggiori L, Ferron M, Panis Y. Functional disorders after rectal cancer resection: does a rehabilitation programme improve anal continence and quality of life? Color Dis. 2012;14(10):1231–7.CrossRef Laforest A, Bretagnol F, Mouazan AS, Maggiori L, Ferron M, Panis Y. Functional disorders after rectal cancer resection: does a rehabilitation programme improve anal continence and quality of life? Color Dis. 2012;14(10):1231–7.CrossRef
45.
Zurück zum Zitat Kuo LJ, Lin YC, Lai CH, Lin YK, Huang YS, Hu CC, et al. Improvement of fecal incontinence and quality of life by electrical stimulation and biofeedback for patients with low rectal cancer after intersphincteric resection. Arch Phys Med Rehabil. 2015;96(8):1442–7.CrossRef Kuo LJ, Lin YC, Lai CH, Lin YK, Huang YS, Hu CC, et al. Improvement of fecal incontinence and quality of life by electrical stimulation and biofeedback for patients with low rectal cancer after intersphincteric resection. Arch Phys Med Rehabil. 2015;96(8):1442–7.CrossRef
46.
Zurück zum Zitat Kye BH, Kim HJ, Kim G, Yoo RN, Cho HM. The effect of biofeedback therapy on anorectal function after the reversal of temporary stoma when administered during the temporary stoma period in rectal cancer patients with sphincter-saving surgery: the interim report of a prospective randomized controlled trial. Medicine. 2016;95(18):e3611.CrossRef Kye BH, Kim HJ, Kim G, Yoo RN, Cho HM. The effect of biofeedback therapy on anorectal function after the reversal of temporary stoma when administered during the temporary stoma period in rectal cancer patients with sphincter-saving surgery: the interim report of a prospective randomized controlled trial. Medicine. 2016;95(18):e3611.CrossRef
47.
Zurück zum Zitat Byrne CM, Solomon MJ, Young JM, Rex J, Merlino CL. Biofeedback for fecal incontinence: short-term outcomes of 513 consecutive patients and predictors of successful treatment. Dis Colon Rectum. 2007;50(4):417–27.CrossRef Byrne CM, Solomon MJ, Young JM, Rex J, Merlino CL. Biofeedback for fecal incontinence: short-term outcomes of 513 consecutive patients and predictors of successful treatment. Dis Colon Rectum. 2007;50(4):417–27.CrossRef
48.
Zurück zum Zitat Lacima G, Pera M, Gonzalez-Argente X, Torrents A, Valls-Sole J, Espuna-Pons M. Is electromyography a predictive test of patient response to biofeedback in the treatment of fecal incontinence? Neurourol Urodyn. 2016;35(3):390–4.CrossRef Lacima G, Pera M, Gonzalez-Argente X, Torrents A, Valls-Sole J, Espuna-Pons M. Is electromyography a predictive test of patient response to biofeedback in the treatment of fecal incontinence? Neurourol Urodyn. 2016;35(3):390–4.CrossRef
Metadaten
Titel
A Practical Guide to Biofeedback Therapy for Pelvic Floor Disorders
verfasst von
Susrutha Puthanmadhom Narayanan
Adil E. Bharucha
Publikationsdatum
01.05.2019
Verlag
Springer US
Erschienen in
Current Gastroenterology Reports / Ausgabe 5/2019
Print ISSN: 1522-8037
Elektronische ISSN: 1534-312X
DOI
https://doi.org/10.1007/s11894-019-0688-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.